2023
DOI: 10.3390/cancers15164039
|View full text |Cite
|
Sign up to set email alerts
|

Beyond the Frontline: A Triple-Line Approach of Thoracic Surgeons in Lung Cancer Management—State of the Art

Abstract: Non-small cell lung cancer (NSCLC) is now described as an extremely heterogeneous disease in its clinical presentation, histology, molecular characteristics, and patient conditions. Over the past 20 years, the management of lung cancer has evolved with positive results. Immune checkpoint inhibitors have revolutionized the treatment landscape for NSCLC in both metastatic and locally advanced stages. The identification of molecular alterations in NSCLC has also allowed the development of targeted therapies, whic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 136 publications
0
0
0
Order By: Relevance
“…Our work addresses this very gap by proposing an innovative method that combines the strengths of multiple existing models. The overarching goal is to arm clinicians with sophisticated tools and methods, facilitating more effective screening, diagnosis, therapeutic planning, image-guided interventions, evaluation of treatment outcomes, and patient monitoring across a myriad of significant medical conditions [2]. Zooming into the specific context of brain tumors, these are characterized by the aberrant proliferation of cells within the cerebral environment [3].…”
Section: Introductionmentioning
confidence: 99%
“…Our work addresses this very gap by proposing an innovative method that combines the strengths of multiple existing models. The overarching goal is to arm clinicians with sophisticated tools and methods, facilitating more effective screening, diagnosis, therapeutic planning, image-guided interventions, evaluation of treatment outcomes, and patient monitoring across a myriad of significant medical conditions [2]. Zooming into the specific context of brain tumors, these are characterized by the aberrant proliferation of cells within the cerebral environment [3].…”
Section: Introductionmentioning
confidence: 99%